Plomp JJ - Search Results

1

Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.

Huijbers MG, Plomp JJ, van Es IE, Fillié-Grijpma YE, Kamar-Al Majidi S, Ulrichts P, de Haard H, Hofman E, van der Maarel SM, Verschuuren JJ. Huijbers MG, et al. Among authors: plomp jj. Exp Neurol. 2019 Jul;317:133-143. doi: 10.1016/j.expneurol.2019.03.001. Epub 2019 Mar 6. Exp Neurol. 2019. PMID: 30851266 Free article.

2

A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.

Molenaar PC, Oen BS, Plomp JJ, Van Kempen GT, Jennekens FG, Hesselmans LF. Molenaar PC, et al. Among authors: plomp jj. Eur J Pharmacol. 1991 Apr 10;196(1):93-101. doi: 10.1016/0014-2999(91)90413-k. Eur J Pharmacol. 1991. PMID: 1874282

3

Acetylcholine release in myasthenia gravis: regulation at single end-plate level.

Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC. Plomp JJ, et al. Ann Neurol. 1995 May;37(5):627-36. doi: 10.1002/ana.410370513. Ann Neurol. 1995. PMID: 7755358

4

Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.

Wintzen AR, Plomp JJ, Molenaar PC, van Dijk JG, van Kempen GT, Vos RM, Wokke JH, Vincent A. Wintzen AR, et al. Among authors: plomp jj. Ann Neurol. 1998 Oct;44(4):657-64. doi: 10.1002/ana.410440412. Ann Neurol. 1998. PMID: 9778265

5

Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness.

Kaja S, van de Ven RC, Broos LA, Veldman H, van Dijk JG, Verschuuren JJ, Frants RR, Ferrari MD, van den Maagdenberg AM, Plomp JJ. Kaja S, et al. Among authors: plomp jj. Neuroscience. 2005;135(1):81-95. doi: 10.1016/j.neuroscience.2005.04.069. Neuroscience. 2005. PMID: 16111830

6

Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya.

Kaja S, van de Ven RC, van Dijk JG, Verschuuren JJ, Arahata K, Frants RR, Ferrari MD, van den Maagdenberg AM, Plomp JJ. Kaja S, et al. Among authors: plomp jj. Eur J Neurosci. 2007 Apr;25(7):2009-20. doi: 10.1111/j.1460-9568.2007.05438.x. Eur J Neurosci. 2007. PMID: 17439489

7

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, Rother RP, Plomp JJ, Willison HJ. Halstead SK, et al. Among authors: plomp jj. Brain. 2008 May;131(Pt 5):1197-208. doi: 10.1093/brain/awm316. Epub 2008 Jan 8. Brain. 2008. PMID: 18184663

8

Neuromuscular synaptic function in mice lacking major subsets of gangliosides.

Zitman FM, Todorov B, Jacobs BC, Verschuuren JJ, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. Zitman FM, et al. Among authors: plomp jj. Neuroscience. 2008 Oct 28;156(4):885-97. doi: 10.1016/j.neuroscience.2008.08.034. Epub 2008 Aug 23. Neuroscience. 2008. PMID: 18801416

9

Neuromuscular synaptic transmission in aged ganglioside-deficient mice.

Zitman FM, Todorov B, Verschuuren JJ, Jacobs BC, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. Zitman FM, et al. Among authors: plomp jj. Neurobiol Aging. 2011 Jan;32(1):157-67. doi: 10.1016/j.neurobiolaging.2009.01.007. Epub 2009 Feb 23. Neurobiol Aging. 2011. PMID: 19233512 Free article.

10

Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.

Niks EH, Kuks JB, Wokke JH, Veldman H, Bakker E, Verschuuren JJ, Plomp JJ. Niks EH, et al. Among authors: plomp jj. Muscle Nerve. 2010 Aug;42(2):283-8. doi: 10.1002/mus.21642. Muscle Nerve. 2010. PMID: 20544919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page